Will Cannabis Genetics Be Banned?
The redefinition of hemp under national law, set to take effect Nov. 12, signals the end of Farm Bill safeguards for many hemp-derived THC items across the country: mild beverages as well as THCA bud and nativesusa.com] delta-8 THC gummies, vapes and other products available at gas stations and smoke shops.
But the hemp ban also creates a major complication for the legitimate cannabis sector. Seeds from cannabis varieties that produce flower with more than 0.3% THC are no longer legal to ship out of state.
Although seed buying will probably continue in authorized states, the changes threaten to close some seed suppliers and genetics companies, observers note, while creating supply-chain issues for cannabis cultivators and retailers.
“If this wording goes through, we will require pop-up shops to offer seeds in each state where it’s permitted,” Campanella said. “Which is why we’re also offering clones and tissue cultivation, because that’s not covered in the bill.”
When are cannabis genetics and clones illegal to ship between state lines?
The new regulations classify seeds based on the THC potential of the mother plant. Genetic substances such as seeds and clones are rendered illegal if the end product exceeds the threshold.
For the moment, seeds are currently shipping under the 2018 Farm Bill’s status quo. But the time is ticking for businesses like Brothers Grimm and for cannabis growers who fear supply chain interruptions if out-of-state access to genetics is prohibited.
Most of the cannabis sector remains largely unaware of the approaching shutdown of the interstate genetics market, said Ryan Power, cofounder of Sebastopol, California-based breeder Atlas Seed.
Without government intervention in the form of a carve-out for seeds or an overall moratorium, numerous seed suppliers will simply be shuttered by November, he added.
“We are functioning legally currently, but if that changes, it will upend the legitimate licensed sector in every state,” said Power, whose customers includes seed banks as well as licensed commercial cultivators.
“Customers are going to lose choice, and it will be a major shutdown for most people.”
What are cannabis seed banks doing to remain legal after the federal hemp ban?
Sagui Silber has already recalibrated Silberhaze Genetics, his Ohio genetics business, because of state Senate Bill 56, which tightened cannabis supervision in that state while also restricting hemp-derived THC items to licensed cannabis retailers.
Previously a seed bank, Silberhaze is now focused on the marketing, preservation and IP safeguarding of premium plant genetics.
That’s because seed businesses hoping to stay compliant in this new environment must have solid documentation, he said.
“You have to demonstrate where this stuff comes from, so it’s extremely important to have documentation, even to the point where you have cultivator names,” Silber said.
“Smaller businesses will have to work with improved records and a better chain of possession,” he added. “We need that documentation ourselves, because we don’t want to be dealing with shady sources.”
To avoid seizures and additional legal fallout, seed entrepreneurs must “get their affairs in order” before the new regulations take place, Silber said.
“Review all your materials immediately, and classify what you can,” Silber said. “Take stock, document your lineage, preserve breeder records, and organize any cannabinoid or terpene information you already have. If regulations change, you’ll be in a much better position to understand what may be affected and make informed decisions.”
Does federal marijuana rescheduling impact cannabis genetics?
Silber believes U.S. Drug Enforcement Administration registration may be required for businesses engaged in research.
But for now, seed companies can’t register with the DEA like state-licensed therapeutic cannabis businesses can. Such a pathway is unavailable to seed suppliers, nurseries or genetics businesses, said Jim Ickes, an attorney and partner with Frantz Ward’s cannabis law group in Cleveland.
“Seed-related activity may be occurring inside broader state-licensed medical marijuana businesses, as some states allow dispensaries or registered medical operators to offer seeds, clones or home-cultivation materials,” he said.
“But that is different from the DEA establishing a freestanding seed bank registration category.”
Some genetics operators are already changing operational practices to conform with the updated law. According to Ickes, they must answer questions including:
- Which of our lines produce plants over 0.3% total THC?
- Which seeds survive as hemp after Nov. 12, 2026, and which don’t?
- What does our inventory look like once we organize it against the genetics exclusion?
Ickes also recognizes confusion from customers who believed government rescheduling of medical marijuana would resolve their story with banking institutions. However, the recent regulatory language has shifted those conversations beyond the basics of classification, he said.
“Banks ask whether this specific revenue source is lawful, whether it connects to state-licensed activity, or whether there’s cross-state risk,” said Ickes.
“After November, a seed supplier selling high-THC genetics can’t address the first question with the hemp classification. It has to refer to a legal state cannabis channel instead. Seed banks dealing in authentic industrial-hemp seed maintain the cleaner story.”
What’s the future of cannabis genetics?
Campanella is part of a new coalition of other breeders, farmers and researchers that’s arguing seeds are better defined as farm inputs than regulated substances. To that effect, seeds should be overseen by the U.S. Department of Agriculture, allowing the DEA to concentrate its enforcement efforts elsewhere.
“How do you regulate something based on what it could become later?” said Campanella. “Our choice is to have that language removed, or get seeds regulated by the USDA as a hemp product.”
But in the meantime, Campanella is restructuring Brothers Grimm to function outside the scope of changing federal oversight. The company plans to keep its Colorado seed facility while positioning its Oklahoma tissue cultivation facility as a safeguard against government prohibition of cannabis seeds.
As she noted: “If things develop in a way where we can’t concentrate on interstate transport, we’ll have other resources to satisfy people’s requirements without putting ourselves in trouble.”
